Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.

Clinical genitourinary cancer - 1 Apr 2014

Ponz-Sarvisé Mariano, Castañón Eduardo, Panizo-Santos Angel, Redrado Miriam, López Inés, Rosell David, Gil-Aldea Isabel, Calvo Alfonso, Nguewa Paul A, Gil-Bazo Ignacio

Abstract excerpt

BACKGROUND: In the prostate-specific antigen era, potentially indolent prostate tumors are radically treated, causing overtreatment. Molecular prognostic factors might differentiate indolent from aggressive tumors, allowing avoidance of unnecessary treatment. PATIENTS AND METHODS: Fifty-two prostate cancer patients (20 organ-confined and 32 metastatic) were selected. All formalin-fixed and paraffin-embedded...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression

Share to Kaplan-Meier Estimate

Share to Prognosis

Share to Proportional Hazards Models

Share to Prostatic Neoplasms

Share to RNA, Messenger

Source

Identifiers

PMID: 24129125
DOI: 10.1016/j.clgc.2013.08.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.PMID 24129125Read ↗

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor GenesSemantic proximity Read ↗

Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer.Semantic proximity Read ↗

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.Semantic proximity Read ↗

Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of MalignancySemantic proximity Read ↗

Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes.Semantic proximity Read ↗

ALDH1-positive intratumoral stromal cells indicate epithelial differentiation and good prognosis in prostate cancerSemantic proximity Read ↗

Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processSemantic proximity Read ↗

ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.Semantic proximity Read ↗

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.Semantic proximity Read ↗

A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate CancerSemantic proximity Read ↗

Downregulation of NDR 1 contributes to metastasis of prostate cancer cells via activating epithelial‐mesenchymal transitionSemantic proximity Read ↗

Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.